Biogen

Contact
biogenidec.de
+49 89 99617 0

Biogen GmbH

Carl-Zeiss-Ring 6
85737 Ismaning
Germany
+49 89 99617 0
biogenidec.de
Contact
Profile News
Contact

About Biogen

Read more about Biogen
Facts about Biogen
  • Focus : Manufacturer
  • Industry : Biotechnology

Similar companies

Merck Life Science KGaA

Merck Life Science KGaA

Darmstadt
Manufacturer
Laboratory analysis / Laboratory measurement technology
Biotechnology
Search companies
Merck Life Science KGaA

Merck Life Science KGaA

Darmstadt
Manufacturer
Laboratory analysis / Laboratory measurement technology
Biotechnology
Search companies

News about Biogen

Biogen

05-Jan-2021 | business & finance

ViGeneron and Biogen collaborate

ViGeneron signs global collaboration agreement for ophthalmic gene therapy development

Read news
Biogen

19-Jan-2017 | business & finance

Siemens and Biogen cooperate

Siemens Healthineers and Biogen announce agreement to jointly develop new MRI tools for multiple sclerosis

Read news
Biogen

01-Sep-2016 | science

Antibody reduces harmful brain amyloid plaques in Alzheimer's patients

Aducanumab, an antibody developed by the University of Zurich, has been shown to trigger a meaningful reduction of harmful beta-amyloid plaques in patients ...

Read news
Biogen

23-Jun-2016 | people

Biogen names executive vice president

Biogen announced the appointment of Paul McKenzie, Ph.D., as executive vice president, Pharmaceutical Operations & Technology, effective July 1, 2016. He ...

Read news
Biogen

19-Jan-2016 | business & finance

First etanercept biosimilar approved in the European Union

Biogen will manufacture and commercialize BENEPALI® in the EU

Read news
Biogen

04-Mar-2015 | research and development

Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix paediatric study

Biogen Idec and Swedish Orphan Biovitrum AB announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, ...

Read news
Biogen

18-Nov-2013 | business & finance

BioFocus Signs Agreement with Biogen Idec in Scleroderma Target Discovery

Identification and validation of novel targets in scleroderma

Read news
Biogen

28-Sep-2012 | research and development

Biogen Idec and Sobi announce positive top-line results from phase 3 study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum (Sobi)announced positive results from B-LONG, a clinical study that evaluated a new long-lasting clotting factor ...

Read news
Show more news about Biogen

Here you will find Biogen GmbH